Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Not all pharma will lose out in Greek tragedy

This article was originally published in Scrip

Executive Summary

Greece stands on the brink of an abyss. Whilst the nation seeks to haul itself away from this chasm of bankruptcy, by throwing itself on the mercy of the International Monetary Fund and Euro member states, its research-based pharmaceutical industry is simultaneously being sucked into the void. But the pharmaceutical arena rarely plays host to a one-sided show. As matters go from bad to worse for originators, other players could be set to benefit from upheaval.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts